Nanoparticles in Medicine: Therapeutic Applications and Developments
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · cited 3×
“One drawback of the use of liposomes is the fast clearance of liposomes from the blood by phagocytic cells of the reticuloendothelial system, resulting in unfavorable therapeutic index.(9) Several strategies have been developed to reduce this problem.”
BackgroundNanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationThe emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 1×
“Poly(D,L-lactic acid), poly(D,L-glycolic acid), poly(e-caprolactone), and their copolymers at various molar ratios diblocked or multiblocked with poly(ethylene glycol) are the most commonly used biodegradable polymers to form micelles for drug delivery and controlled release, and have been extensively studied in the p…”
BackgroundMoghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Roy, I., Ohulchanskyy, T. Y., Pudavar, H. E., Bergey, E. J., Oseroff, A. R., Morgan, J., Dougherty, T. J., & Prasad, P. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0343095 · Cited by 929
Cited by
Items 101–200 of 204
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Khameneh, B., Diab, R., Ghazvini, K., & Fazly Bazzaz, B. S. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.009 · Cited by 345
Mohanty, S., Mishra, S., Jena, P., Jacob, B., Sarkar, B., & Sonawane, A. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.11.007 · Cited by 344
Upconverting and NIR emitting rare earth based nanostructures for NIR-bioimaging
Hemmer, E., Venkatachalam, N., Hyodo, H., Hattori, A., Ebina, Y., Kishimoto, H., & Soga, K. (2013) · Nanoscale · doi:10.1039/c3nr02286b · Cited by 343
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
Role of integrated cancer nanomedicine in overcoming drug resistance
Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343
Pati, R., Mehta, R. K., Mohanty, S., Padhi, A., Sengupta, M., Vaseeharan, B., Goswami, C., & Sonawane, A. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.02.012 · Cited by 336
Cao, Z., & Jiang, S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.001 · Cited by 329
Deng, S., Gigliobianco, M. R., Censi, R., & Di Martino, P. (2020) · Nanomaterials · doi:10.3390/nano10050847 · Cited by 329
Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Subbiah, R., Veerapandian, M., & S. Yun, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710794183024 · Cited by 327
Electrochemical nanoarchitectonics and layer-by-layer assembly: From basics to future
Rydzek, G., Ji, Q., Li, M., Schaaf, P., Hill, J. P., Boulmedais, F., & Ariga, K. (2015) · Nano Today · doi:10.1016/j.nantod.2015.02.008 · Cited by 326
Synthesis and Biomedical Applications of Multifunctional Nanoparticles
Kim, D., Shin, K., Kwon, S. G., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201802309 · Cited by 317
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 316
Self-citationEffects of engineered nanoparticles on the innate immune system
Liu, Y., Hardie, J., Zhang, X., & Rotello, V. M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.011 · Cited by 315
Mulet, X., Boyd, B. J., & Drummond, C. J. (2013) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.10.014 · Cited by 315
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Lu, Y., Yue, Z., Xie, J., Wang, W., Zhu, H., Zhang, E., & Cao, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0234-x · Cited by 313
Recent advances in materials for extended-release antibiotic delivery system
Gao, P., Nie, X., Zou, M., Shi, Y., & Cheng, G. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.58 · Cited by 310
Lipid-based nanovesicles for nanomedicine
Grimaldi, N., Andrade, F., Segovia, N., Ferrer-Tasies, L., Sala, S., Veciana, J., & Ventosa, N. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00409a · Cited by 309
Mohanta, Y. K., Biswas, K., Jena, S. K., Hashem, A., Abd_Allah, E. F., & Mohanta, T. K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01143 · Cited by 308
Polysaccharide nanoparticles: from fabrication to applications
Plucinski, A., Lyu, Z., & Schmidt, B. V. K. J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00628b · Cited by 308
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
Self-citationModi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 307
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
Choi, H. S., Ipe, B. I., Misra, P., Lee, J. H., Bawendi, M. G., & Frangioni, J. V. (2009) · Nano Letters · doi:10.1021/nl900872r · Cited by 305
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C.-M. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D.-E., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 302
Self-citationSundin, G. W., Castiblanco, L. F., Yuan, X., Zeng, Q., & Yang, C. (2016) · Molecular Plant Pathology · doi:10.1111/mpp.12436 · Cited by 299
Zhou, H., Fan, Z., Deng, J., Lemons, P. K., Arhontoulis, D. C., Bowne, W. B., & Cheng, H. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00820 · Cited by 293
Nanomaterials for agriculture, food and environment: applications, toxicity and regulation
Kaphle, A., Navya, P. N., Umapathi, A., & Daima, H. K. (2018) · Environmental Chemistry Letters · doi:10.1007/s10311-017-0662-y · Cited by 293
Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K., Huang, C.-M., & Zhang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111110e · Cited by 293
Self-citationPRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Rapid Delivery of Drug Carriers Propelled and Navigated by Catalytic Nanoshuttles
Kagan, D., Laocharoensuk, R., Zimmerman, M., Clawson, C., Balasubramanian, S., Kang, D., Bishop, D., Sattayasamitsathit, S., Zhang, L., & Wang, J. (2010) · Small · doi:10.1002/smll.201001257 · Cited by 290
Self-citationHigh-Quality CuInS2/ZnS Quantum Dots for In vitro and In vivo Bioimaging
Deng, D., Chen, Y., Cao, J., Tian, J., Qian, Z., Achilefu, S., & Gu, Y. (2012) · Chemistry of Materials · doi:10.1021/cm3015594 · Cited by 290
Applications of Noble Metal-Based Nanoparticles in Medicine
Klębowski, B., Depciuch, J., Parlińska-Wojtan, M., & Baran, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124031 · Cited by 289
Perspectives on the past, present, and future of cancer nanomedicine
Youn, Y. S., & Bae, Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.008 · Cited by 285
Role of nanotechnology behind the success of mRNA vaccines for COVID-19
Khurana, A., Allawadhi, P., Khurana, I., Allwadhi, S., Weiskirchen, R., Banothu, A. K., Chhabra, D., Joshi, K., & Bharani, K. K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101142 · Cited by 284
Xu, Z., Wang, Y., Zhang, L., & Huang, L. (2014) · ACS Nano · doi:10.1021/nn500216y · Cited by 284
Self-citationNanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds
Zuhrotun, A., Oktaviani, D. J., & Hasanah, A. N. (2023) · Molecules · doi:10.3390/molecules28073240 · Cited by 281
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
Davatgaran-Taghipour, Y., Masoomzadeh, S., Farzaei, M. H., Bahramsoltani, R., Karimi-Soureh, Z., Rahimi, R., & Abdollahi, M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131973 · Cited by 281
Hansen, A. E., Petersen, A. L., Henriksen, J. R., Boerresen, B., Rasmussen, P., Elema, D. R., Rosenschöld, P. M. A., Kristensen, A. T., Kjær, A., & Andresen, T. L. (2015) · ACS Nano · doi:10.1021/acsnano.5b01324 · Cited by 277
Relating Cytotoxicity, Zinc Ions, and Reactive Oxygen in ZnO Nanoparticle–Exposed Human Immune Cells
Shen, C., James, S. A., de Jonge, M. D., Turney, T. W., Wright, P. F. A., & Feltis, B. N. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft187 · Cited by 272
Nanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Self-citationWerner, M. E., Cummings, N. D., Sethi, M., Wang, E. C., Sukumar, R., Moore, D. T., & Wang, A. Z. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.009 · Cited by 267
“Advances in nanomedicine have enabled the development of many NP-based chemotherapeutics (14).”
BackgroundApplication of Nanotechnology in Drug Delivery
(2014) · InTech eBooks · doi:10.5772/57028 · Cited by 266
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Rosenholm, J. M., Mamaeva, V., Sahlgren, C., & Lindén, M. (2012) · Nanomedicine · doi:10.2217/nnm.11.166 · Cited by 263
Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment
Saleem, J., Wang, L., & Chen, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800525 · Cited by 262
Dixit, S., Novak, T., Miller, K., Zhu, Y., Kenney, M. E., & Broome, A.-M. (2015) · Nanoscale · doi:10.1039/c4nr04853a · Cited by 262
Advancements in microfluidics for nanoparticle separation
Salafi, T., Zeming, K. K., & Zhang, Y. (2017) · Lab on a Chip · doi:10.1039/c6lc01045h · Cited by 261
Softer Zwitterionic Nanogels for Longer Circulation and Lower Splenic Accumulation
Zhang, L., Cao, Z., Li, Y., Ella-Menye, J.-R., Bai, T., & Jiang, S. (2012) · ACS Nano · doi:10.1021/nn301159a · Cited by 260
Self-citationRecent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Su, S., & M. Kang, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090837 · Cited by 259
Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review
Brohi, R. D., Wang, L., Talpur, H. S., Wu, D., Khan, F. A., Bhattarai, D., Rehman, Z.-U., Farmanullah, F., & Huo, L.-J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00606 · Cited by 259
Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials
Tsou, Y., Zhang, X., Zhu, H., Syed, S., & Xu, X. (2017) · Small · doi:10.1002/smll.201701921 · Cited by 258
Kuthati, Y., Kankala, R. K., & Lee, C.-H. (2015) · Applied Clay Science · doi:10.1016/j.clay.2015.04.018 · Cited by 258
Strategic design of extracellular vesicle drug delivery systems
Armstrong, J. P. K., & Stevens, M. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.017 · Cited by 257
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Mamo, T., Moseman, E. A., Kolishetti, N., Salvador-Morales, C., Shi, J., Kuritzkes, D. R., Langer, R., Andrian, U. V., & Farokhzad, O. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.1 · Cited by 255
Self-citationSpatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
Self-citationBharali, D. J., & Mousa, S. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.007 · Cited by 251
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Khang, D., Lee, Y. K., Choi, E.-J., Webster, T. J., & Kim, S.-H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72998 · Cited by 244
“1,2,4 In drug delivery systems, for example, conventional (micron-sized) particles are quickly cleared by the immune system and can only enter phagocytic cells, whereas NP-based drugs can be delivered to all organs and, thus, all cells.”
Anand, K., Gengan, R. M., Phulukdaree, A., & Chuturgoon, A. (2015) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2014.05.021 · Cited by 241
Towards applications of bioentities@MOFs in biomedicine
Velásquez-Hernández, M. D. J., Linares-Moreau, M., Astria, E., Carraro, F., Alyami, M. Z., Khashab, N. M., Sumby, C. J., Doonan, C. J., & Falcaro, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213651 · Cited by 233
Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles
Tao, J., Chow, S. F., & Zheng, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.001 · Cited by 232
Core–shell nanostructures: perspectives towards drug delivery applications
Kumar, R., Mondal, K., Panda, P. K., Kaushik, A., Abolhassani, R., Ahuja, R., Rubahn, H.-G., & Mishra, Y. K. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01559h · Cited by 227
Non-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Self-citationTherapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
“Many types of nanocarriers including liposomes, solid lipid NPs and polymeric NPs have been developed to deliver a variety of drugs [9-11].”
Self-citationWu, W., Shen, J., Banerjee, P., & Zhou, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.061 · Cited by 222
Sonawnae, A., Jena, Mohanty, Mallick, & Jacob (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28077 · Cited by 220
Dendrimers in combination with natural products and analogues as anti-cancer agents
Mignani, S., Rodrigues, J., Tomas, H., Zablocka, M., Shi, X., Caminade, A.-M., & Majoral, J.-P. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00550d · Cited by 219
Can Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2013) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 210
Biocompatibility of transition metal-substituted cobalt ferrite nanoparticles
Sanpo, N., Tharajak, J., Li, Y., Berndt, C. C., Wen, C., & Wang, J. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2510-3 · Cited by 210
“Nanotechnology concerns the understanding and control of matters in the 1–100 nm range, at which scale materials have unique physicochemical properties, including ultra small size, large surface to mass ratio, high reactivity, and unique interactions with biological systems (Zhang et al. 2007).”
BackgroundFuchs, A.-K., Syrovets, T., Haas, K. A., Loos, C., Musyanovych, A., Mailänder, V., Landfester, K., & Simmet, T. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.064 · Cited by 209
Cell Membrane Coated Nanoparticles: next-generation Therapeutics
Narain, A., Asawa, S., Chhabria, V., & Patil-Sen, Y. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0225 · Cited by 207
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K.-T., Burnett, J., & Rossi, J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 205
“A nanotechnology approach to drug delivery focuses on developing nanoscale particles (1-1,000 nm) to deliver drugs to a specific site, extend their bioavailability, improve their biodistribution, reduce their immunogenicity and toxicity and improve their efficacy [64–66].”
BackgroundKibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.012 · Cited by 200
“They have been shown to enhance the therapeutic activity of several anticancer drugs [1].”
Nanoparticulate Systems for Growth Factor Delivery
Zhang, S., & Uludağ, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9897-z · Cited by 196
Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems
Sitterberg, J., Özcetin, A., Ehrhardt, C., & Bakowsky, U. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.005 · Cited by 187
Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine
Nam, J.-S., Sharma, A., Nguyen, L., Chakraborty, C., Sharma, G., & Lee, S.-S. (2016) · Molecules · doi:10.3390/molecules21010108 · Cited by 179
“The physicochemical properties of liposomes such as size, surface charge, composition and targeting ligand can be modulated according to the drug, site of action and the disease, making it feasible for controlled and specific delivery system [151].”
BackgroundPotential applications and human biosafety of nanomaterials used in nanomedicine
Su, H., Wang, Y., Gu, Y., Bowman, L., Zhao, J., & Ding, M. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3476 · Cited by 178
Coordination polymer nanoparticles in medicine
Novio, F., Simmchen, J., Vázquez-Mera, N., Amorín-Ferré, L., & Ruiz-Molina, D. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.04.022 · Cited by 178
Stimuli-Responsive Liposome Fusion Mediated by Gold Nanoparticles
Pornpattananangkul, D., Olson, S., Aryal, S., Sartor, M., Huang, C.-M., Vecchio, K., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9018587 · Cited by 173
“The success of PEGylated liposomes has led to a group of clinically approved therapeutic products for systemic drug delivery, including Doxil, AmBisome, DaunoXome, DepoCyt, and Visudyne.3,17 Although the polymer-coated liposomes have shown great success for systemic drug delivery, they are less frequently used for der…”
Self-citationLeveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Boyer, C., Bulmus, V., Priyanto, P., Teoh, W. Y., Amal, R., & Davis, T. P. (2009) · J. Mater. Chem. · doi:10.1039/b815202k · Cited by 169
van der Valk, F. M., van Wijk, D. F., Lobatto, M. E., Verberne, H. J., Storm, G., Willems, M. C. M., Legemate, D. A., Nederveen, A. J., Calcagno, C., Mani, V., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.02.021 · Cited by 169
Nanoparticles of Titanium and Zinc Oxides as Novel Agents in Tumor Treatment: a Review
Bogdan, J., Pławińska-Czarnak, J., & Zarzyńska, J. (2017) · Nanoscale Research Letters · doi:10.1186/s11671-017-2007-y · Cited by 167
“Moreover, the smaller the NP diameter, the longer becomes the blood circulation time [28].”
BackgroundAn overview of nanoparticles in drug delivery: Properties and applications
Hsu, C.-Y., Rheima, A. M., Kadhim, M. M., Ahmed, N. N., Mohammed, S. H., Abbas, F. H., Abed, Z. T., Mahdi, Z. M., Abbas, Z. S., Hachim, S. K., et al. (2023) · South African Journal of Chemical Engineering · doi:10.1016/j.sajce.2023.08.009 · Cited by 165
Targeted nanoparticles in mitochondrial medicine
Pathak, R. K., Kolishetti, N., & Dhar, S. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1305 · Cited by 161
Remotely actuated shape memory effect of electrospun composite nanofibers
Gong, T., Li, W., Chen, H., Wang, L., Shao, S., & Zhou, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.12.006 · Cited by 147
Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020146 · Cited by 144
“Over the last decades, the number of nanopharmaceuticals being approved for market commercialization expanded intensively and is now a reality in the medical field [34].”
BackgroundEbrahim Attia, A. B., Yang, C., Tan, J. P. K., Gao, S., Williams, D. F., Hedrick, J. L., & Yang, Y.-Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.042 · Cited by 131
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116
Sun, Q., You, Q., Wang, J., Liu, L., Wang, Y., Song, Y., Cheng, Y., Wang, S., Tan, F., & Li, N. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b13651 · Cited by 109
Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells
Safwat, M. A., Soliman, G. M., Sayed, D., & Attia, M. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.076 · Cited by 109
Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity
Sethi, M., Sukumar, R., Karve, S., Werner, M. E., Wang, E. C., Moore, D. T., Kowalczyk, S. R., Zhang, L., & Wang, A. Z. (2014) · Nanoscale · doi:10.1039/c3nr05961h · Cited by 102
Self-citationZnO and TiO2 nanoparticles as novel antimicrobial agents for oral hygiene: a review
Khan, S. T., Al-Khedhairy, A. A., & Musarrat, J. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3074-6 · Cited by 100
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
Schon, H.-T., Bartneck, M., Borkham-Kamphorst, E., Nattermann, J., Lammers, T., Tacke, F., & Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00033 · Cited by 97
“Strictly taken, nanoparticles are sized from one up to 10 nm, however, the definition is frequently being extended to the submicron range up to 500 nm (Zhang et al., 2008).”
BackgroundDrug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells
Saadat, M., Zahednezhad, F., Zakeri-Milani, P., Reza Heidari, H., Shahbazi-Mojarrad, J., & Valizadeh, H. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30318 · Cited by 88
“Thus, well designing NPs in targeting to the cell cytoplasm is essential for imaging and therapy goals (5), phototherapy (6) and drug targeting (7).”
BackgroundAxial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives
Kiaie, S. H., Mojarad-Jabali, S., Khaleseh, F., Allahyari, S., Taheri, E., Zakeri-Milani, P., & Valizadeh, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119269 · Cited by 87
Li, X., Yang, X., Lin, Z., Wang, D., Mei, D., He, B., Wang, X., Wang, X., Zhang, Q., & Gao, W. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.04.018 · Cited by 56
Hwang, D., Ramsey, J. D., Makita, N., Sachse, C., Jordan, R., Sokolsky-Papkov, M., & Kabanov, A. V. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.037 · Cited by 40
“Among a variety of drug delivery systems, the most successful approach thus far is the encapsulation of physicochemically challenging active pharmaceutical ingredients (APIs) in nanoparticles [6,7].”
BackgroundGupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27
Metadata
- Authors
- Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 83
- Issue
- 5
- Pages
- 761-769
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2089155556
- Cited by
- 2,657
- References
- 47
- FWCI
- 22.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.